← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2009Last known activity
Apr 8, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 8 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT06357221OfficialPhase 4Apr 8, 2024
- NCT06042647Lead sponsorPhase 4Jul 13, 2023
- NCT05872256Lead sponsorPhase 4Jun 1, 2023
- NCT05872256Overall official - principal investigatorPhase 4Jun 1, 2023
- NCT05872256OfficialPhase 4Jun 1, 2023
- NCT05278624Reponsible party - principal investigatorPhase 2Apr 15, 2022
- NCT05278624Lead sponsorPhase 2Apr 15, 2022
- NCT05226143Overall official - principal investigatorN/AFeb 21, 2022
- NCT01355458Overall official - principal investigatorPhase 3May 1, 2011
- NCT01174030Overall official - principal investigatorPhase 2Aug 1, 2010
- NCT00987545CollaboratorPhase 2Jun 1, 2009
Details
- Founded
- High Point, NC, US
- Last known activity
- Apr 8, 2024